show index hide index
As part of an innovative initiative, Airbus is leveraging its expertise in artificial intelligence to revolutionize cancer treatment. Through a multidisciplinary partnership with the Oncopole of Toulouse and Accuray, the European aircraft manufacturer is developing advanced solutions to improve the availability and performance of radiotherapy equipment. The main objective is to optimize the diagnosis and monitoring of patients using AI technologies capable of predicting and preventing failures in medical systems. Thanks to these advances, cancer treatment is becoming more precise and effective, offering new perspectives in the fight against this disease.
Airbus, in partnership with the Toulouse Oncopole University Cancer Institute (IUCT-Oncopole) and Accuray, is leveraging its expertise in artificial intelligence (AI) to transform cancer treatment. This project aims to improve the prediction of radiotherapy equipment failures and optimize treatment performance, thus offering a new dimension to the fight against this disease.
A multidisciplinary partnership
In Toulouse, Airbus initiated a collaboration with IUCT-Oncopole and Accuray to develop intelligent solutions for health. This collective partnership is committed to using AI to predict system performance issues in oncology, including radiotherapy. By combining the skills of an aerospace leader with those of medical experts, the project aims to revolutionize the way medical equipment is managed and maintained.
Failure prediction using AI
The reliability of medical equipment is crucial to ensuring effective and continuous treatments. Using advanced AI algorithms, Airbus is working on predicting radiotherapy machine failures. This prediction makes it possible to anticipate and prevent service interruptions, thus ensuring maximum equipment availability for cancer patients.
Optimization of radiotherapy treatments
One of the primary objectives of this project is to improve the effectiveness of radiotherapy treatments. The technologies developed allow devices to detect the size and movement of tumors with unprecedented precision. The systems can then adapt in real time to the contours of the tumor, thus increasing the effectiveness of the treatment and reducing collateral damage to healthy tissues.
AI in the service of cancer research
Airbus and its partners also leverage AI to analyze large medical databases. Artificial intelligence helps interpret and process this data, thereby identifying new trends and improving cancer diagnosis. This data-driven approach opens new perspectives for the research and development of innovative treatments.
The fight against cancer accelerated by AI
The use of artificial intelligence by Airbus as part of this partnership with Oncopole is a concrete example of how AI can transform the field of health. By combining cutting-edge technology and medical expertise, this project significantly contributes to the fight against cancer, offering new chances of cure to patients and optimizing available resources.
